Nuclear IL-33 in Fibroblasts Promotes Skin Fibrosis.
作者信息
Park Jong Ho, Mortaja Mahsa, Azin Marjan, Nazarian Rosalynn M, Demehri Shadmehr
机构信息
Center for Cancer Immunology and Cutaneous Biology Research Center, Department of Dermatology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
出版信息
J Invest Dermatol. 2023 Jul;143(7):1302-1306.e4. doi: 10.1016/j.jid.2022.12.019. Epub 2023 Jan 26.
Abstract
摘要
相似文献
1
Nuclear IL-33 in Fibroblasts Promotes Skin Fibrosis.
J Invest Dermatol. 2023 Jul;143(7):1302-1306.e4. doi: 10.1016/j.jid.2022.12.019. Epub 2023 Jan 26.
2
Thy-1 promotes skin fibrosis in SSc.
Nat Rev Rheumatol. 2022 Nov;18(11):613. doi: 10.1038/s41584-022-00858-5.
3
Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.
Arthritis Rheum. 2013 Jan;65(1):236-46. doi: 10.1002/art.37706.
4
Inhibitory Regulation of Skin Fibrosis in Systemic Sclerosis by Apelin/APJ Signaling.
Arthritis Rheumatol. 2018 Oct;70(10):1661-1672. doi: 10.1002/art.40533. Epub 2018 Aug 23.
5
Molecular and cellular basis of scleroderma.
J Mol Med (Berl). 2014 Sep;92(9):913-24. doi: 10.1007/s00109-014-1190-x. Epub 2014 Jul 18.
6
Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis.
Arch Dermatol. 1996 Jul;132(7):802-6.
7
Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis.
Nat Commun. 2021 Oct 12;12(1):5947. doi: 10.1038/s41467-021-26099-w.
8
Elevated interleukin-11 in systemic sclerosis and role in disease pathogenesis.
J Dermatol. 2023 Oct;50(10):1255-1261. doi: 10.1111/1346-8138.16854. Epub 2023 Jun 8.
9
10
[Research advances on the role of aerobic glycolysis in skin fibrosis diseases].
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2024 Apr 20;40(4):389-394. doi: 10.3760/cma.j.cn501225-20230712-00004.
引用本文的文献
1
Magnolin Mitigates Skin Ageing Through the CXCL10/p38 Signalling Pathway.
J Cell Mol Med. 2025 May;29(10):e70507. doi: 10.1111/jcmm.70507.
2
Unpacking the complexity of nuclear IL-33 (nIL-33): a crucial regulator of transcription and signal transduction.
J Cell Commun Signal. 2023 Dec;17(4):1131-1143. doi: 10.1007/s12079-023-00788-1. Epub 2023 Oct 25.
本文引用的文献
1
IL-33/Regulatory T-Cell Axis Suppresses Skin Fibrosis.
J Invest Dermatol. 2022 Oct;142(10):2668-2676.e4. doi: 10.1016/j.jid.2022.03.009. Epub 2022 Mar 25.
2
PDGF Promotes Dermal Fibroblast Activation a Novel Mechanism Mediated by Signaling Through MCHR1.
Front Immunol. 2021 Nov 29;12:745308. doi: 10.3389/fimmu.2021.745308. eCollection 2021.
3
Nuclear IL-33/SMAD signaling axis promotes cancer development in chronic inflammation.
EMBO J. 2021 Apr 1;40(7):e106151. doi: 10.15252/embj.2020106151. Epub 2021 Feb 22.
4
Nuclear IL-33 restrains the early conversion of fibroblasts to an extracellular matrix-secreting phenotype.
Sci Rep. 2021 Jan 8;11(1):108. doi: 10.1038/s41598-020-80509-5.
5
Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis.
J Mol Cell Cardiol. 2019 Mar;128:179-186. doi: 10.1016/j.yjmcc.2019.01.018. Epub 2019 Feb 11.
6
IL-33/ST2 Axis in Organ Fibrosis.
Front Immunol. 2018 Oct 24;9:2432. doi: 10.3389/fimmu.2018.02432. eCollection 2018.
7
marks a cellular lineage with distinct contributions to myofibroblasts in lung maturation and injury response.
Elife. 2018 Sep 4;7:e36865. doi: 10.7554/eLife.36865.
8
IL-33 Can Promote the Process of Pulmonary Fibrosis by Inducing the Imbalance Between MMP-9 and TIMP-1.
Inflammation. 2018 Jun;41(3):878-885. doi: 10.1007/s10753-018-0742-6.
9
Recent advances in the treatment of skin involvement in systemic sclerosis.
Inflamm Regen. 2017 Jun 12;37:12. doi: 10.1186/s41232-017-0047-4. eCollection 2017.
10
Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.
Immunol Rev. 2018 Jan;281(1):154-168. doi: 10.1111/imr.12619.
Zotero 插件